Automated Insulin Delivery for Inpatients With Dysglycemia

Automated Insulin Delivery for Inpatients With Dysglycemia

Conditions: Type 1 Diabetes; Type 2 Diabetes
Interventions: Device: AID system with Remote Real-Time CGM; Combination Product: Standard of Care Insulin Therapy + CGM
Sponsors: Emory University; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

May 21, 2024Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments